Stay updated on Efficacy of Pexidartinib in TGCT Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.

Latest updates to the Efficacy of Pexidartinib in TGCT Clinical Trial page
- ChecktodayChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2 while the page remained a 403 error page.SummaryDifference0.2%

- Check7 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1, while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating restricted access to the study record. The header and footer remain visible, while the main content is replaced with an access-denied message.SummaryDifference18%

- Check49 days agoChange DetectedThe page's revision indicator was updated from v3.6.5 to v3.6.6, reflecting a minor version bump in the site's metadata.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.6.5 replaces v3.6.4, indicating a new page version. The change does not modify the study data or visible content.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page revision stamp was updated from v3.6.3 to v3.6.4, indicating a new version of the page. The visible content and behavior remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Pexidartinib in TGCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.